January 31, 2008 11:03 ET

Emerging Equity Alert for Thursday, January 31, 2008: RXAF to Launch 35 New Products!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - January 31, 2008) - announces the following stocks to its Breaking News List: Rx for Africa, Inc. (PINKSHEETS: RXAF), Novell, Inc. (NASDAQ: NOVL), Harmonic Inc (NASDAQ: HLIT), Cadence Design Systems, Inc. (NASDAQ: CDNS).

Visit TheSUBWAY's Small Cap Investor Forum Here: to discuss our daily stock picks throughout the trading day!

Rx Africa (Ethiopia) PLC, the wholly owned generic drug manufacturing subsidiary of Rx for Africa, Inc. (PINKSHEETS: RXAF), is positioned to benefit greatly from powerful new incentives for Ethiopia's local pharmaceutical industry put into place by the Federal Government of Ethiopia.

Dr. Mulugetta Bezzabeh, Chairman of Rx for Africa, Inc. said, "Over the next year, we will launch over 35 new products, many in high demand by the government for clinics and hospitals. Last year the government purchased US $400 million of medications, and this amount is growing.

"To further promote the local industry, the government has placed a tariff ranging from 15-30% on pharmaceutical imports and the Federal Drug Authority of Ethiopia has issued new directives preventing the import of drugs that are similar to those that are produced in sufficient quantity in Ethiopia. This is of enormous help to us, as well. We will be more productive under these favorable conditions."

Other stocks highlighted include Novell, Inc. (NASDAQ: NOVL): Hot Stocks List, down 1% on 5 million shares, Harmonic Inc (NASDAQ: HLIT): Hot Stocks List, up 13% on 5 million shares, Cadence Design Systems, Inc. (NASDAQ: CDNS): Hot Stocks List, up 1% on 5 million shares.'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRGP may be compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has not been compensated but may receive up to fifteen thousand dollars for RXAF. CRGP intends to sell its shares. CRGP has sold approximately zero MNDP shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site operate under a license from Capital Research Group, Inc., Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's Licensors, affiliates, officers, directors and employees own shares and intend to buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information